Back to search
Isocitrate Dehydrogenase Gene Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Isocitrate Dehydrogenase Gene Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Isocitrate Dehydrogenase Gene Mutation trials you may qualify forBackground: Diffuse gliomas are tumors that affect the brain and spinal cord. Gliomas that develop in people with certain gene mutations (IDH1 or IDH2) are esp…
This study will investigate the use of hyperpolarized (HP) carbon-13 (13C) alpha-ketoglutarate (aKG) (HP 13C-aKG) to characterize tumor burden in participants w…
maintenance of AML or MDS patients with known IDH1 mutation after allogeneic stem cell transplantation within past 100 days
This phase II trial studies how well olaparib works in treating patients with acute myeloid leukemia that has come back (relapsed) or does not respond to treatm…
An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in advanced or metastatic solid tumor…
This phase I trial studies the side effects and best dose of BGB-290 and temozolomide in treating adolescents and young adults with IDH1/2-mutant grade I-IV gli…